Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis.
作者信息
Freidlin Julie, Wong Ira G, Acharya Nisha
出版信息
Br J Ophthalmol. 2007 Oct;91(10):1414. doi: 10.1136/bjo.2006.113316.
Abstract
摘要
相似文献
1
Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis.利妥昔单抗治疗与韦格纳肉芽肿相关的周边溃疡性角膜炎。
Br J Ophthalmol. 2007 Oct;91(10):1414. doi: 10.1136/bjo.2006.113316.
2
The use of Campath in severe peripheral ulcerative keratitis associated with Wegener's granulomatosis.Campath在与韦格纳肉芽肿相关的严重周边溃疡性角膜炎中的应用。
Eye (Lond). 2006 Dec;20(12):1453-4. doi: 10.1038/sj.eye.6702330. Epub 2006 Apr 7.
3
Rituximab for peripheral ulcerative keratitis with wegener granulomatosis.利妥昔单抗治疗韦格纳肉芽肿性外周溃疡性角膜炎。
Cornea. 2010 Jun;29(6):708-10. doi: 10.1097/ICO.0b013e3181c296ed.
4
[Severe Wegener's granulomatosis successfully treated with rituximab].利妥昔单抗成功治疗重症韦格纳肉芽肿病
Ter Arkh. 2010;82(6):53-5.
5
Corneal autoimmunity in patients with peripheral ulcerative keratitis (PUK) in association with rheumatoid arthritis and Wegener's granulomatosis.外周溃疡性角膜炎（PUK）患者合并类风湿性关节炎和韦格纳肉芽肿时的角膜自身免疫反应。
Eye (Lond). 1992;6 ( Pt 6):630-6. doi: 10.1038/eye.1992.136.
6
B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.利妥昔单抗治疗难治性头颈部韦格纳肉芽肿的B细胞清除：一项队列研究。
Clin Otolaryngol. 2009 Aug;34(4):328-35. doi: 10.1111/j.1749-4486.2009.01968.x.
7
Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.利妥昔单抗在难治性眼部韦格纳肉芽肿的治疗中有效。
Arthritis Rheum. 2009 May;60(5):1540-7. doi: 10.1002/art.24454.
8
Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.难治性韦格纳肉芽肿：利妥昔单抗对肉芽肿性双侧眼眶受累的影响。
Isr Med Assoc J. 2009 Sep;11(9):566-8.
9
Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.利妥昔单抗成功治疗韦格纳肉芽肿相关巩膜炎。
Br J Ophthalmol. 2005 Nov;89(11):1542. doi: 10.1136/bjo.2005.075689.
10
Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.利妥昔单抗治疗局限性韦格纳肉芽肿伴难治性肉芽肿表现的疗效。
J Rheumatol. 2008 Oct;35(10):2017-23. Epub 2008 Aug 1.
引用本文的文献
1
Efficacy of Rituximab on Refractory Organ Involvements in Granulomatosis with Polyangiitis: A Systematic Review of Case Reports.利妥昔单抗治疗肉芽肿伴多血管炎难治性器官受累的疗效：病例报告的系统评价。
Curr Rheumatol Rev. 2024;20(3):270-283. doi: 10.2174/0115733971263964231020072640.
2
The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎的疗效及安全性：一项系统评价
Biology (Basel). 2022 Dec 6;11(12):1767. doi: 10.3390/biology11121767.
3
Peripheral Ulcerative Keratitis: A Review.周边溃疡性角膜炎：综述
J Ophthalmic Vis Res. 2022 Apr 29;17(2):252-275. doi: 10.18502/jovr.v17i2.10797. eCollection 2022 Apr-Jun.
4
Rituximab for non-infectious Uveitis and Scleritis.利妥昔单抗用于非感染性葡萄膜炎和巩膜炎。
J Ophthalmic Inflamm Infect. 2021 Aug 16;11(1):23. doi: 10.1186/s12348-021-00252-4.
5
Two cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy.两例类风湿关节炎并发角膜溃疡穿孔经生物治疗成功治愈。
BMC Rheumatol. 2020 Feb 7;4:6. doi: 10.1186/s41927-019-0108-1. eCollection 2020.
6
An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.儿童慢性非感染性葡萄膜炎治疗的最新进展
Curr Treatm Opt Rheumatol. 2017 Mar;3(1):1-16. doi: 10.1007/s40674-017-0057-z. Epub 2017 Jan 29.
7
Biologic therapy for refractory scleritis: a new treatment perspective.难治性巩膜炎的生物治疗：一种新的治疗视角。
Int Ophthalmol. 2015 Dec;35(6):903-12. doi: 10.1007/s10792-015-0124-0. Epub 2015 Aug 29.
8
Infliximab for peripheral ulcerative keratitis treatment.英夫利昔单抗用于外周溃疡性角膜炎的治疗。
Medicine (Baltimore). 2014 Nov;93(26):e176. doi: 10.1097/MD.0000000000000176.
9
New indications for biological therapies.生物疗法的新适应证。
Intern Emerg Med. 2011 Oct;6 Suppl 1:1-9. doi: 10.1007/s11739-011-0667-7.
10
Rituximab in refractory Vogt-Koyanagi-Harada disease.利妥昔单抗治疗难治性葡萄膜大脑炎
J Ophthalmic Inflamm Infect. 2011 Dec;1(4):177-80. doi: 10.1007/s12348-011-0027-9. Epub 2011 Jul 9.
本文引用的文献
1
Consensus statement on the use of rituximab in patients with rheumatoid arthritis.关于利妥昔单抗在类风湿关节炎患者中应用的共识声明。
Ann Rheum Dis. 2007 Feb;66(2):143-50. doi: 10.1136/ard.2006.061002. Epub 2006 Oct 26.
2
Biologic therapies for inflammatory eye disease.用于炎症性眼病的生物疗法。
Clin Exp Ophthalmol. 2006 May-Jun;34(4):365-74. doi: 10.1111/j.1442-9071.2006.01225.x.
3
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎患者的长期观察
Rheumatology (Oxford). 2006 Nov;45(11):1432-6. doi: 10.1093/rheumatology/kel098. Epub 2006 Apr 21.
4
Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.利妥昔单抗成功治疗韦格纳肉芽肿相关巩膜炎。
Br J Ophthalmol. 2005 Nov;89(11):1542. doi: 10.1136/bjo.2005.075689.
5
Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.9例抗中性粒细胞胞浆抗体阳性血管炎患者接受利妥昔单抗治疗成功。
J Intern Med. 2005 Jun;257(6):540-8. doi: 10.1111/j.1365-2796.2005.01494.x.
Zotero 插件